Regeneron Pharmaceuticals, Inc. (REGN)
840.04
-11.99
(-1.41%)
USD |
NASDAQ |
Sep 03, 10:42
Regeneron Pharmaceuticals Research and Development Expense (Annual) : 5.306B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.306B |
| December 31, 2024 | 4.624B |
| December 31, 2023 | 3.987B |
| December 31, 2022 | 3.056B |
| December 31, 2021 | 2.622B |
| December 31, 2020 | 2.499B |
| December 31, 2019 | 2.240B |
| December 31, 2018 | 2.038B |
| December 31, 2017 | 1.930B |
| December 31, 2016 | 1.948B |
| December 31, 2015 | 1.546B |
| December 31, 2014 | 1.219B |
| December 31, 2013 | 818.74M |
| December 31, 2012 | 588.61M |
| December 31, 2011 | 498.42M |
| December 31, 2010 | 469.56M |
| December 31, 2009 | 384.52M |
| December 31, 2008 | 266.73M |
| Date | Value |
|---|---|
| December 31, 2007 | 190.13M |
| December 31, 2006 | 122.12M |
| December 31, 2005 | 137.92M |
| December 31, 2004 | 136.10M |
| December 31, 2003 | 136.02M |
| December 31, 2002 | 124.95M |
| December 31, 2001 | 91.54M |
| December 31, 2000 | 56.26M |
| December 31, 1999 | 44.94M |
| December 31, 1998 | 37.05M |
| December 31, 1997 | 27.77M |
| December 31, 1996 | 28.27M |
| December 31, 1995 | 22.52M |
| December 31, 1994 | 29.93M |
| December 31, 1993 | 35.68M |
| December 31, 1992 | 23.11M |
| December 31, 1991 | 12.79M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| AbbVie, Inc. | 8.249B |
| Gilead Sciences, Inc. | 5.688B |
| Amgen, Inc. | 6.974B |
| Biogen, Inc. | 1.481B |